本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BIOTRON LIMITED

0.003
0.000
成交量:567.24萬
成交額:1.67萬
市值:810.56萬
市盈率:-2.06
高:0.003
開:0.003
低:0.002
收:0.003
52周最高:0.005
52周最低:0.002
股本:27.02億
流通股本:11.65億
量比:3.96
換手率:0.49%
股息:- -
股息率:- -
每股收益(TTM):-0.001
每股收益(LYR):0.000
淨資產收益率:-122.62%
總資產收益率:-50.99%
市淨率:3.00
市盈率(LYR):-9.43

資料載入中...

公司資料

公司名字:
BIOTRON LIMITED
交易所:
ASX
成立時間:
1999
員工人數:
3
公司地址:
66 Hunter Street,Level 2,Sydney,New South Wales,Australia
郵編:
2000
傳真:
61 2 9221 6333
簡介:
Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.